KMT2A REARRANGEMENT

Clinical trials for KMT2A REARRANGEMENT explained in plain language.

Never miss a new study

Get alerted when new KMT2A REARRANGEMENT trials appear

Sign up with your email to follow new studies for KMT2A REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug trial aims to stop blood Cancer's comeback after transplant

Disease control Recruiting now

This early-stage study is testing whether adding an experimental drug called ziftomenib to standard care after a bone marrow transplant is safe and can help keep acute myeloid leukemia (AML) from coming back. The study will enroll about 22 adults with specific genetic types of AM…

Matched conditions: KMT2A REARRANGEMENT

Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

KMT2A REARRANGEMENT

Get alerted when new KMT2A REARRANGEMENT trials appear

New drug trial aims to stop blood Cancer's comeback after transplant